SVA-24930-77979
4 vaccinations
4 coded responses
39 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 017 / MA
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AQM-19661-19624
Child or adolescent in my care · Male · 2022-09-05
Timeline
-
2021-02-18
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Survey response — days 1–6 daily, dose 1MedDRA: Paranasal sinus discomfort — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessFree text: Sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-03-07
- 2021-03-14
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-21
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
-
2021-04-04
Survey response — day 14, dose 2MedDRA: Anovulatory cycle — Feeling: GoodFree text: Anovulatory cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2021-11-22
Dose 3 — Pfizer-BioNTech
- 2021-12-01
- 2021-12-08
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 35, dose 3MedDRA: Headache, Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Stuffy/runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
- 2022-02-21
- 2022-05-25
-
2022-09-09
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-20
- 2022-09-25
- 2022-10-01
- 2022-10-07
-
2022-10-14
Survey response — day 35, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | Flu |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Sinus pressure
Release 6 — day 14, dose 2
Symptoms: Anovulatory cycle
Release 10 — day 35, dose 3
Symptoms: Stuffy/runny nose, headache
Release 12 — day 35, dose 4
Symptoms: Sore throat, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anovulatory cycle | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release